GlossaryCKD-Mineral and Bone Disorder (CKD-MBD)

CKD-Mineral and Bone Disorder (CKD-MBD)

Updated June 18, 2026

CKD-Mineral and Bone Disorder (CKD-MBD) is a broad clinical syndrome that encompasses the systemic abnormalities in mineral metabolism and skeletal health caused by kidney failure. While often used interchangeably with Renal Secondary Hyperparathyroidism (RSHP), CKD-MBD is the wider "umbrella" term that covers three specific components: abnormal blood levels of minerals (Calcium, Phosphorus, and Magnesium), imbalances in hormones (PTH and Vitamin D), and the resulting abnormalities in bone structure and soft tissue calcification. In the healthy cat, the kidneys activate Vitamin D into Calcitriol, which is essential for absorbing calcium from food. As kidney tissue dies, Calcitriol production plummets. Combined with high phosphorus levels, this creates a "perfect storm" where the body cannot maintain calcium balance. The body attempts to compensate by leaching calcium from the skeleton, leading to Renal Osteodystrophy (weak, rubbery bones) and depositing that calcium into soft tissues like the heart, lungs, and kidneys (metastatic calcification). Management requires a multi-pronged approach involves strict phosphorus control and, in specific cases, supplementation with active Vitamin D (Calcitriol) to protect bone integrity.

Disclaimer: This content is for educational purposes only and does not constitute veterinary medical advice. Always consult with your primary care veterinarian or a veterinary internal medicine specialist regarding your cat’s specific condition.